We need a frontline drug for Melanoma

new-zealand-labour-party

Fri Feb 12 2016 13:00:00 GMT+1300 (New Zealand Daylight Time)

We need a frontline drug for Melanoma

Friday, 12 February 2016, 11:18 am
Press Release: New Zealand Labour Party

We need a frontline drug for Melanoma

Pharmac’s latest refusal to fund Keytruda means thousands of melanoma sufferers are still without a front line drug, says Labour’s Health spokesperson Annette King.

“Pharmac must at least offer Keytruda as a temporary solution until more long-term data is available. At the moment it’s scandalous that people are dying because there is no effective treatment funded for advanced melanoma.

“Labour supports the Cancer Society’s view that the new drugs like Keytruda are a ‘quantum leap’ over anything now available to melanoma patients.

“We must restore equity into cancer treatment. We can no longer have a system where people mortgage their homes to prolong and save their lives.

“There has been no meaningful increase in the medicines budget. For the last five years Government spending on Pharmac has been virtually stagnant.

“It’s appalling a drug that New Zealand melanoma sufferers claim is leading to remissions in tumours, remains available to only those who are able to afford it,” says Annette King.

ENDS

Advertisement - scroll to continue reading

a.supporter:hover {background:#EC4438!important;} @media screen and (max-width: 480px) { #byline-block div.byline-block {padding-right:16px;}}

Using Scoop for work?

Scoop is free for personal use, but you’ll need a licence for work use. This is part of our Ethical Paywall and how we fund Scoop. Join today with plans starting from less than $3 per week, plus gain access to exclusive Pro features.

Join Pro Individual Find out more

Find more from New Zealand Labour Party on InfoPages.